Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01581437 · ClinicalTrials.gov registry record · NA

Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram Maps

A NA study of Atrial Fibrillation, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT01581437 is a NA study of Atrial Fibrillation that has completed, run by Virginia Commonwealth University. The registered enrollment target is 78 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01581437, a NA study of Atrial Fibrillation, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The 64 pole basket catheter used for the mapping procedure will be defined "atypical" sites which sustain atrial fibrillation. The ablation through the driver will lead to more rapid ablation of the atrial fibrillation.

Conditions Studied

Interventions

  • PROCEDURE 64 pole basket catheter

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2011-10
Est. Completion 2013-12
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT01581437

The ClinicalTrials.gov registry entry for NCT01581437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which 64 pole basket catheter is the first listed.

NCT01581437 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01581437 about?

NCT01581437 is a clinical study titled "Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram Maps". The 64 pole basket catheter used for the mapping procedure will be defined "atypical" sites which sustain atrial fibrillation. The ablation through the driver will lead to more rapid ablation of the atrial fibrillation.

What is the current status of trial NCT01581437?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2011-10. Estimated completion is 2013-12.

What conditions does trial NCT01581437 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT01581437?

The interventions under investigation include: 64 pole basket catheter (PROCEDURE).

Who is sponsoring clinical trial NCT01581437?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01581437 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.